Inflammatory biomarkers and abacavir use in the Women's Interagency HIV Study and the Multicenter AIDS Cohort Study
- PMID: 20588104
- PMCID: PMC3514460
- DOI: 10.1097/QAD.0b013e3283389dfa
Inflammatory biomarkers and abacavir use in the Women's Interagency HIV Study and the Multicenter AIDS Cohort Study
Abstract
Objective: To assess associations between abacavir (ABC) use and systemic inflammation.
Design: Nested case-control study.
Methods: The Multicenter AIDS Cohort Study (MACS) and Women's Interagency HIV Study (WIHS) cohort participants who initiated ABC were matched, using propensity score methods, to ABC-unexposed persons. Levels of high-sensitivity C-reactive protein (hsCRP) (microg/ml), interleukin-6 (IL-6) (pg/ml), and D-dimer (microg/ml) were measured from pre-HAART and on-HAART plasma. Random-effects models compared markers by ABC exposure and by changes from pre-HAART levels.
Results: Biomarkers were measured in N = 508 matched pairs (328 women; 180 men). Pre-HAART levels did not differ by exposure group except that hsCRP levels were higher among WIHS women who subsequently used ABC (P = 0.04). Regardless of ABC use, mean hsCRP increases and D-dimer reductions were seen when comparing pre-HAART to on-HAART levels, in the overall group (28 and -27%), for MACS men (28 and -31%) and for WIHS women [29 and -24%, P < 0.01 for all]; IL-6 levels declined in MACS men (P = 0.02). No adjusted biomarker level differences existed by ABC exposure at the on-HAART visit. HIV RNA reductions correlated with D-dimer (r = 0.14, P < 0.01) and IL-6 (r = 0.12, P < 0.01) reductions. Associations between ABC use and mean biomarker levels were modified by pre-HAART antiretroviral therapy experience. Renal dysfunction was equally likely among non-ABC and ABC recipients.
Discussion: ABC use was not associated with plasma elevations in hsCRP, IL-6, and D-dimer. Mechanisms other than increased systemic inflammation may account for ABC's reported association with increased cardiovascular disease. HAART-associated reductions in D-dimer and IL-6 were apparent regardless of ABC use and were correlated with HIV RNA reductions.
Figures
Similar articles
-
Interleukin-2 cycling causes transient increases in high-sensitivity C-reactive protein and D-dimer that are not associated with plasma HIV-RNA levels.AIDS. 2009 Sep 24;23(15):2015-9. doi: 10.1097/QAD.0b013e32832d72c6. AIDS. 2009. PMID: 19617815 Free PMC article. Clinical Trial.
-
Comparison of cardiovascular disease risk markers in HIV-infected patients receiving abacavir and tenofovir: the nucleoside inflammation, coagulation and endothelial function (NICE) study.Antivir Ther. 2014;19(2):141-7. doi: 10.3851/IMP2681. Epub 2013 Aug 28. Antivir Ther. 2014. PMID: 23985706 Free PMC article.
-
Early changes in inflammatory and pro-thrombotic biomarkers in patients initiating antiretroviral therapy with abacavir or tenofovir.BMC Infect Dis. 2011 Feb 4;11:40. doi: 10.1186/1471-2334-11-40. BMC Infect Dis. 2011. PMID: 21294867 Free PMC article. Clinical Trial.
-
Abacavir and lamivudine for the treatment of human immunodeficiency virus.Expert Opin Pharmacother. 2011 Sep;12(13):2129-38. doi: 10.1517/14656566.2011.602631. Epub 2011 Jul 25. Expert Opin Pharmacother. 2011. PMID: 21787242 Review.
-
Effects of nucleoside reverse transcriptase inhibitor backbone on the efficacy of first-line boosted highly active antiretroviral therapy based on protease inhibitors: meta-regression analysis of 12 clinical trials in 5168 patients.HIV Med. 2009 Oct;10(9):527-35. doi: 10.1111/j.1468-1293.2009.00724.x. HIV Med. 2009. PMID: 19785663 Review.
Cited by
-
A randomized controlled trial assessing the effects of raltegravir intensification on endothelial function in treated HIV infection.J Acquir Immune Defic Syndr. 2012 Nov 1;61(3):317-25. doi: 10.1097/QAI.0b013e31826e7d0f. J Acquir Immune Defic Syndr. 2012. PMID: 22918156 Free PMC article. Clinical Trial.
-
Inflammation markers after randomization to abacavir/lamivudine or tenofovir/emtricitabine with efavirenz or atazanavir/ritonavir.AIDS. 2012 Jul 17;26(11):1371-85. doi: 10.1097/QAD.0b013e328354f4fb. AIDS. 2012. PMID: 22546988 Free PMC article. Clinical Trial.
-
HIV Infection and Acute Stroke: A Case Report and a Review of the Literature.Case Rep Med. 2013;2013:892054. doi: 10.1155/2013/892054. Epub 2013 Aug 29. Case Rep Med. 2013. PMID: 24073002 Free PMC article.
-
T cell activation predicts carotid artery stiffness among HIV-infected women.Atherosclerosis. 2011 Jul;217(1):207-13. doi: 10.1016/j.atherosclerosis.2011.03.011. Epub 2011 Mar 15. Atherosclerosis. 2011. PMID: 21492857 Free PMC article.
-
Brief Report: Higher ART Adherence Is Associated With Lower Systemic Inflammation in Treatment-Naive Ugandans Who Achieve Virologic Suppression.J Acquir Immune Defic Syndr. 2018 Apr 15;77(5):507-513. doi: 10.1097/QAI.0000000000001629. J Acquir Immune Defic Syndr. 2018. PMID: 29346185 Free PMC article.
References
-
- Lundgren J, Reiss P, Worm S, Weber R, El-Sadr W, De Wit S, et al. Risk of Myocardial Infarction with Exposure to Specific ARV from the PI, NNRTI, and NRTI Drug Classes: The D:A:D. Study 16th Conference on Retroviruses and Opportunistic Infections (CROI 2009); February 8 - 11, 2009; Montreal, Canada. Abstract 44LB.
-
- Lang S, Mary-Krause M, Cotte L, 2, Gilquin G, Partisani M, Simon A, et al. Impact of Specific NRTI and PI Exposure on the Risk of Myocardial Infarction: A Case-Control Study Nested within FHDH ANRS CO4. 16th Conference on Retroviruses and Opportunistic Infections (CROI 2009); February 8 - 11, 2009; Montreal, Canada. Abstract 43LB.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous